University of Hertfordshire

From the same journal

By the same authors

Blood/plasma secretome and microvesicles

Research output: Contribution to journalReview article

  • Jameel M Inal
  • Uchini Kosgodage
  • Sarah Azam
  • Dan Stratton
  • Samuel Antwi-Baffour
  • Sigrun Lange
View graph of relations
Original languageEnglish
Number of pages9
Pages (from-to)2317-25
JournalBiochimica et Biophysica Acta - Biomembranes
Journal publication dateNov 2013
Volume1834
Issue11
DOIs
Publication statusPublished - Nov 2013

Abstract

A major but hitherto overseen component of the blood/plasma secretome is that of extracellular vesicles (EVs) which are shed from all blood cell types. These EVs are made up of microvesicles (MVs) and exosomes. MVs, 100nm-1μm in diameter, are released from the cell surface, and are a rich source of non-conventionally secreted proteins lacking a conventional signal peptide, and thus not secreted by the classical secretory pathways. Exosomes are smaller vesicles (≤100nm) having an endocytic origin and released upon multivesicular body fusion with the plasma membrane. Both vesicle types play major roles in intercellular cross talk and constitute an important component of the secretome especially in the area of biomarkers for cancer. The release of EVs, which are found in all the bodily fluids, is enhanced in cancer and a major focus of cancer proteomics is therefore targeted at EVs. The blood/plasma secretome is also a source of EVs, potentially diagnostic of infectious disease, whether from EVs released from infected cells or from the pathogens themselves. Despite the great excitement in this field, as is stated here and in other parts of this Special issue entitled: An Updated Secretome, much of the EV research, whether proteomic or functional in nature, urgently needs standardisation both in terms of nomenclature and isolation protocols. This article is part of a Special Issue entitled: An Updated Secretome.

ID: 13069102